These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 8927533)
21. [Immunobiology--the neglected side of transfusion]. Flesland O; Solheim BG Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2493. PubMed ID: 11070981 [No Abstract] [Full Text] [Related]
22. [The role of quality control systems in the blood bank]. Blanco L Sangre (Barc); 1995 Dec; 40(6):517-8. PubMed ID: 8850238 [No Abstract] [Full Text] [Related]
23. International views on universal leucodepletion: the perspective in NBS, England. Wallington T Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150 [No Abstract] [Full Text] [Related]
24. Good laboratory practice before and after blood transfusion. Moore BP Haematologia (Budap); 1986; 19(4):241-50. PubMed ID: 3817607 [TBL] [Abstract][Full Text] [Related]
25. [Strategies and management of hospital blood center services for safety and efficacy of blood transfusion]. Tsukimoto I; Shigeta K Rinsho Byori; 1991 Mar; Suppl 88():195-204. PubMed ID: 1856968 [No Abstract] [Full Text] [Related]
26. The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS. Mahony BO; Turner A Vox Sang; 2010 Apr; 98(3 Pt 2):447-50. PubMed ID: 20158697 [No Abstract] [Full Text] [Related]
28. [Situation and perspectives of blood transfusion in Togo]. Ségbéna AY; Fétéké L; Bikandou B; Awitala EJ; Koura AG Transfus Clin Biol; 2009; 16(5-6):460-3. PubMed ID: 19896405 [TBL] [Abstract][Full Text] [Related]
29. Quality assurance of blood components prepared in the blood transfusion center/blood bank. Vox Sang; 1994; 67(1):99-111. PubMed ID: 7975467 [No Abstract] [Full Text] [Related]
30. ISBT Board response to the Dublin consensus statement. Flanagan P Vox Sang; 2011 Feb; 100(2):250-1. PubMed ID: 20946536 [No Abstract] [Full Text] [Related]
31. Is the gift still good? Examining the politics and regulation of blood safety in the European Union. Farrell AM Med Law Rev; 2006; 14(2):155-79. PubMed ID: 16831820 [No Abstract] [Full Text] [Related]
32. [State and perspectives of the French haemovigilance system. Presentation of the data collected over 9 years]. David B Transfus Clin Biol; 2003 Jun; 10(3):131-9. PubMed ID: 12798845 [No Abstract] [Full Text] [Related]
33. [Quality standards and quality control of plasma]. Fürst G Beitr Infusionsther; 1991; 28():49-55. PubMed ID: 1725660 [No Abstract] [Full Text] [Related]
35. [Quality indicators and dashboards: the experience of a collection department]. Danic B; Bécel C; Beauplet A Transfus Clin Biol; 2000 Apr; 7(2):189-97. PubMed ID: 10812662 [TBL] [Abstract][Full Text] [Related]
36. Can the supply and demand for plasma-derived products ever be reconciled? Self-sufficiency from the viewpoint of a blood transfusion service. Leikola J Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S15-7. PubMed ID: 7795132 [TBL] [Abstract][Full Text] [Related]
37. Estimation of the probability of post transfusion hepatitis in hemophilia treatment. Davis CE; Grizzle JE; Bryan JA Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517 [No Abstract] [Full Text] [Related]
38. A Swedish blood organization. Wikman A Transfusion; 2007 Aug; 47(2 Suppl):169S-171S; discussion 182S-183S. PubMed ID: 17651345 [No Abstract] [Full Text] [Related]
39. Hemovigilance for improvement of blood safety. Robillard P; Chan P; Kleinman S Transfus Apher Sci; 2004 Oct; 31(2):95-8. PubMed ID: 15501413 [No Abstract] [Full Text] [Related]
40. Summary of the Caribbean subregional workshop on quality in immunohematology, a collaborative effort to improve international blood transfusion services. Cruz JR; Harmening DM; Nance SJ Immunohematology; 2008; 24(1):1-3. PubMed ID: 18393588 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]